Four things to know · April 15, 2026
Sermorelin
Sermorelin Acetate
Sermorelin is a peptide that signals your pituitary gland to produce more growth hormone.
Noticed in days · Full benefit in weeks
Week 1-2
IGF-1 levels typically begin to rise. Many people notice improved sleep quality and faster recovery from workouts.
Week 2-4
Early body composition changes typically begin. Energy levels and general sense of well-being commonly start to improve.
Week 4-8
Typically visible improvements in muscle tone and fat reduction. Skin quality often improves as collagen production increases.
Week 8-12
Sustained body composition improvements continue. IGF-1 levels reach a steady, elevated baseline.
Sermorelin is a peptide that signals your pituitary gland to produce more growth hormone. It was FDA-approved in 1997 for children with growth hormone deficiency and was taken off the market in 2008 for manufacturing reasons, not safety concerns. Because it works through your body's own signaling system, growth hormone is released in natural pulses rather than as a constant stream. That makes it one of the gentler options in this category.
How it works
Sermorelin binds to receptors on the pituitary gland (the small gland at the base of your brain that controls growth hormone). This binding triggers the gland to release growth hormone in its natural pulse pattern. Because sermorelin works upstream of growth hormone itself, your body's built-in feedback loops stay intact, preventing overproduction. The result is a controlled increase in growth hormone that follows your body's own rhythm.
Key benefits
What the research shows:
- ✓FDA-approved track record dating back to 1997
- ✓Absorbed well through injection, with effects beginning within minutes
- ✓Maintains your body's natural growth hormone pulse pattern
- ✓Preserves pituitary function rather than overriding it
Related goals
Regulatory status
Originally FDA-approved in 1997 as Geref for pediatric growth hormone deficiency; brand discontinued in 2008 for manufacturing reasons. Sermorelin was never on the September 2023 Category 2 list and is legally compoundable by 503A pharmacies today as a component of a previously FDA-approved drug. Prohibited under WADA S2 as an explicitly named GHRH analogue, with no therapeutic use exemption available for athletes.
Protocols
| Protocol | Dose | Frequency |
|---|---|---|
| Longevity and wellness | 200-300 mcg daily | Once at bedtime |
| Athletic support | 300-500 mcg daily | Once at bedtime |
| Pediatric GH deficiency (clinical) | 30 mcg/kg daily | Once at bedtime |
| Diagnostic use (clinical setting) | 1 mcg/kg IV | Single dose |
| Body composition focus | 200 mcg daily | 5 days weekly |
| Combined with GHRP | 200 mcg + GHRP | Once daily |
Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.
What people report
IGF-1 levels typically begin to rise. Many people notice improved sleep quality and faster recovery from workouts.
Early body composition changes typically begin. Energy levels and general sense of well-being commonly start to improve.
Typically visible improvements in muscle tone and fat reduction. Skin quality often improves as collagen production increases.
Sustained body composition improvements continue. IGF-1 levels reach a steady, elevated baseline.
What to know
- ⚠Injection site reactions are reported in about 17% of patients but are generally mild and temporary
- ⚠About 6.5% of users develop hypothyroidism over time; thyroid function should be monitored
- ⚠IGF-1 levels should be checked monthly at first, then every 3-6 months once stable
- ⚠Avoid if you have active cancer, pituitary tumors, or are pregnant
- ⚠Was FDA-approved from 1997 to 2008; discontinued for manufacturing reasons, not safety
KEY RESEARCH · 4 PAPERS CITED
The Pep Dispatch
Follow the evidence on Sermorelin as it evolves.
Subscribe to find out what.
Next dispatch · May 2026 · Honest frequency: a few times a month
For the people who want to feel better — not just look up symptoms.